Table 1. Characteristics of participants in this study.

Group	Number	Age (years), mean (range)	Sex (male/female)	HCV-RNA (106 IU/mL), mean (range)	HCV genotype	Liver status	ALT (U/L)
Patients with chronic HCV infection	40	50 (19 to 64)	23/17	18.04 (0.0269–58.9)	1b (n=25), 2a (n=13), 3a (n=2)	Non-cirrhotic FibroScan F1-F2	61.41±102.78
Healthy participants	40	36 (23 to 45)	7/33	N/A	N/A	Normal	22.52±11.64
Patients with SVR	12	46 (19 to 58)	9/3	N/A	1b (n=8), 2a (n=4)	Non-cirrhotic FibroScan F1-F2	38.25±19.85

N/A, not applicable; ALT, alanine transaminase.